Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • Ensign_Crab@lemmy.world
    link
    fedilink
    English
    arrow-up
    25
    ·
    1 year ago

    We need to shorten the term for patents and make patent extension more difficult for this reason alone.